Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies.

Journal Article

Study participants were asked about their interest in switching to novel drug delivery systems that reduce the dosing frequency of antiretroviral regimens. Across a diverse, treatment-experienced cohort, we describe greatest interest in switching to an oral regimen taken once weekly, followed by injections taken every other month and twice-annual implants.

Full Text

Duke Authors

Thielman, Nathan Maclyn

Cited Authors

Derrick, CB; Ostermann, J; Weissman, SB; Hobbie, A; Alshareef, N; Weinhold, A; Yelverton, V; Thielman, NM

Published Date

October 22, 2018

Published In

Open Forum Infectious Diseases

Volume / Issue

5 / 10

Start / End Page

ofy247 -

PubMed ID

30364593

Pubmed Central ID

30364593

Electronic International Standard Serial Number (EISSN)

2328-8957

International Standard Serial Number (ISSN)

2328-8957

Digital Object Identifier (DOI)

10.1093/ofid/ofy247

Language

eng